We extracted GLP-1 RAs (exenatide, liraglutide, dulaglutide, lixisenatide, semaglutide, tirzepatide) and DPP-4 inhibitors (linagliptin, alogliptin, saxagliptin, sitagliptin) from Q1 2013 to Q1 2024 for all AEs classified as biliary disorders (SMQ), with the drug role selecting the primary suspect drug (PS)
These include: Nausea (affecting 20-40% of patients initially) Vomiting Diarrhoea Constipation Abdominal discomfort These symptoms can be debilitating during the first few weeks of treatment and may cause fatigue, reduced appetite, and general malaise
A practical starting plan looks like this: choose one reliable breakfast, one reliable lunch, two to three easy protein options, and a few backup foods for rough days
Avoid standard oral glutathione capsules
Which Is Better for Gym-Goers
Learn More Bulk Supplier Discounts Scale confidently with high-volume pricing, consistent stock, and streamlined logistics